TapImmune to Participate at Two Upcoming Industry Conferences

JACKSONVILLE, Florida – August 29, 2018TapImmune Inc. (NASDAQ: TPIV), a clinical-stage immuno-oncology company, today announced that its President and CEO, Peter L. Hoang, will participate at two upcoming industry conferences.  Mr. Hoang will present and participate in a panel discussion at the Hanson Wade CAR-TCR Summit, to be held September 4-7, 2018, in Boston, Massachusetts, and present at BioCentury’s 25th Annual NewsMakers in the Biotech Industry to be held September 7, 2018, in New York City.

 

CAR-TCR Summit Details:

Date: Wednesday, September 5, 2018

Location: Cityview Room; Seaport Hotel and World Trade Center, Boston, MA

Time: 2:25pm (ET): Company Presentation

5:15pm (ET): Panel – How to Make CAR/TCR Therapies Work Beyond the CD19/ALL Paradigm

 

BioCentury Newsmakers Presentation Details:

Date: Friday, September 7, 2018

Location: Millennium Broadway Hotel & Conference Center, New York City, NY

Time: 2:30pm (ET): Presentation – Room 302/303

3:00pm (ET): Breakout Session – Room 301

Webcast: Available at  http://markertherapeutics.com/events[/vc_column_text][vc_empty_space height=”4px”][vc_column_text][pr-disclaimer2]